Properties of the retained N-terminal hydrophobic leader sequence in human serum paraoxonase/arylesterase

Chemico-Biological Interactions

Volumn 119-120, Issue , 1999, Pages 243-249

  Sorenson, Robert C ^a,b   Aviram, Michael ^c   Bisgaier, Charles L ^d   Billecke, Scott ^a   Hsu, Cary ^a   La Du, Bert N ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b OAKWOOD HOSPITAL AND MEDICAL CENTER   (United States)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d PFIZER INC   (United States)

Author keywords

Apolipoproteins; High density lipoproteins; Low density lipoprotein oxidation; Phospholipid; Site directed mutagenesis

Indexed keywords

APOLIPOPROTEIN; ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; SIGNAL PEPTIDE;

BINDING SITE; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME BINDING; HUMAN; LIPID OXIDATION; MUTANT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTECTION; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING;

ANIMALS; APOLIPOPROTEIN A-I; ARYLDIALKYLPHOSPHATASE; CARBOXYLIC ESTER HYDROLASES; CATTLE; CHICKENS; CHOLESTEROL; COPPER; ESTERASES; HUMANS; KINETICS; LIPOPROTEINS; LIPOPROTEINS, LDL; MUTAGENESIS, SITE-DIRECTED; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PHOSPHOLIPIDS; PROTEIN BINDING; PROTEIN SORTING SIGNALS;

BOVINAE;

EID: 0033063879     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(99)00033-2     Document Type: Conference Paper

References (12)

1. Watson A.D., Berliner J.A., Hama S.Y., La Du B.N., Faull K.F., Fogelman A.M., Navab M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J. Clin. Invest. 96:1995;288-291.
2. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S.L., La Du B.N. Paraoxonase inhibits high density lipoprotein oxidation and preserves its functions: a possible peroxidative role for paraoxonase. J. Clin. Invest. 101:1998;1581-1590.
3. Mackness M.I., Arrol S., Abbott C., Durrington P.N. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis. 104:1993;129-135.
4. Kuo C.L., La Du B.N. Comparison of purified human and rabbit serum paraoxonases. Drug Metab. Dispos. 23:1995;935-944.
5. Hassett C., Richter R.J., Humbert R., Chapline C., Crabb J.W., Omiecinski C.J., Furlong C.E. Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence. Biochemistry. 30:1991;10141-10149.
6. Furlong C.E., Richter R.J., Chapline C., Crabb J.W. Purification of rabbit and human serum paraoxonase. Biochemistry. 30:1991;10133-10140.
7. Sorenson R.C., Primo-Parmo S.L., Kuo C.L., Adkins S., Lockridge O., La Du B.N. Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase. Proc. Natl. Acad. Sci. USA. 92:1995;7187-7191.
8. Ausubel F.M., Brent R., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K. Current Protocols in Molecular Biology. 1993;Wiley, New York.
9. Eckerson H.W., Wyte C.M., La Du B.N. The human serum paraoxonase/arylesterase polymorphism. Am. J. Hum. Genet. 35:1983;1126-1138.
10. Chen C.-H., Albers J.J. Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin:cholesterol acyltransferase activity. J. Lipid Res. 23:1982;680-691.
11. Aviram M., Billecke S., Sorenson R., Bisgaier C., Newton R., Rosenblat M., Erogul J., Hsu C., Dunlop C., La Du B. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different than that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R. Arterioscler. Thromb. Vasc. Biol. 18:1998;1617-1624.
12. Forte T.M., Bielicki J.K., Goth-Goldstein R., Selmek J., McCall M.R. Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT. J. Lipid Res. 36:1995;148-157.